ArticleNeurocritical care2026
Increased Antidepressant Use after Intensive Care for Aneurysmal Subarachnoid Haemorrhage: A Machine-Learning-Enhanced Propensity-Matched Nationwide Cohort Study.
Article in Neurocritical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundMood disorders after aneurysmal subarachnoid haemorrhage (aSAH) are common. Meanwhile, mood disorders are also common after intensive care for any reason, and whether aSAH confers an excess risk remains unknown.
methodsIn this retrospective study, patients with cases of aSAH admitted to intensive care in 2012-2023 were identified in nationwide registers and antidepressant (AD) prescriptions used as a proxy for mood disorders. The primary outcome was incidence of AD therapy in patients who were previously AD-naïve, along with attributable risk factors and impact on sick leave and disability pensions. To investigate the risk of AD treatment in aSAH exceeding what would be expected after intensive care, a control cohort of all patients in the intensive care unit (ICU) nationwide between 2012 and 2018 was identified. Using machine-learning-driven nearest-neighbour propensity score (PS) matching, the relative risk of AD treatment in ICU-treated aSAH cases vs. non-neurovascular ICU cases was calculated.
resultsIn all, 3149 patients with aSAH who were AD-naïve were identified, with a cumulative incidence of AD treatment within 1 year of 25.5% and markers of disease severity being the main risk factors for AD treatment. Patients with aSAH who were treated with ADs used significantly more sick leave and disability pensions than patients with aSAH who were not treated with ADs. After propensity score matching with a general ICU cohort, patients with aSAH still had a risk ratio (RR) of 1.333 [95% confidence interval (CI) 1.241-1.425] of AD treatment within 1 year, indicating an additional impact of aSAH on the development of mood disorders.
conclusionsOur results suggest patients with aSAH have a risk of mood disorders exceeding what would be expected after intensive care for non-neurovascular reasons.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.